Showing 921-930 of 1768 results for "".
The Intersection of Dermatology and Infectious Disease: A Visual Guide
https://practicaldermatology.com/topics/infections-infectious-disease/the-intersection-of-dermatology-and-infectious-disease-a-visual-guide/23386/Recognizing the cutaneous signs and symptoms of infectious diseases is key in early diagnosis and harm reduction.Game-changing Suturing Techniques
https://practicaldermatology.com/topics/skin-cancer-photoprotection/game-changing-suturing-techniques/20464/Implement these buried suture techniques for better outcomes.Fillers for the Décolletage Area
https://practicaldermatology.com/topics/practice-management/fillers-for-the-dcolletage-area/21113/Fillers offer patients an alternative to device-based interventions for chest rejuvenation.o, MDHow Will You Be Remembered? Building a Work Legacy
https://practicaldermatology.com/topics/practice-management/how-will-you-be-remembered-building-a-work-legacy/21124/Five attributes are commonly shared by leaders who eventually become legends.New Drugs for Treating Fungal Infections
https://practicaldermatology.com/topics/general-topics/new-drugs-for-treating-fungal-infections/21426/A review of recent developments for efficacious treatment.Lupus erythematosus tumidus vs Jessner's lymphocytic infiltrate of the Skin
https://practicaldermatology.com/topics/general-topics/lupus-erythematosus-tumidus-vs-jessners-lymphocytic-infiltrate-of-the-skin/21686/A systematic comparison of clinical and histologic characteristics.Dermatology Q&A: New Directions in the Treatment of Hypopigmented Scars
https://practicaldermatology.com/topics/general-topics/dermatology-qa-new-directions-in-the-treatment-of-hypopigmented-scars/21980/A new study shows that off-label use of an unexpected agent yields promising results in the repigmentation of hypopigmented scars.Advanced Management Solutions for High-Grade Cutaneous Toxicities to Cancer Therapy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advanced-management-solutions-for-high-grade-cutaneous-toxicities-to-cancer-therapy/57176/The emergence of immune checkpoint inhibitors (ICIs) has fundamentally altered the prognosis for patients with advanced skin malignancies, yet the high incidence of cutaneous immune-related adverse events (irAEs) remains a significant barrier to treatment continuity. Here, we review the clinical manComorbidities in Psoriasis
https://practicaldermatology.com/topics/psoriasis/comorbidities-in-psoriasis/54453/Psoriasis is associated with numerous systemic comorbidities, many of which are linked through IL-17/IL-23-mediated inflammation. Comorbid conditions such as diabetes, IBD, metabolic syndrome, and PsA are not only more prevalent but often more severe in psoriasis patients, highlighting the importanBiological and Environmental Factors in Facial Eczema
https://practicaldermatology.com/topics/atopic-dermatitis/biological-and-environmental-factors-in-facial-eczema/54270/